Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.71 USD
−38.64 M USD
4.02 M USD
48.36 M
About BIOINVENT INTERNATIONAL AB
Sector
Industry
CEO
Martin Welschof
Website
Headquarters
Lund
Founded
1997
ISIN
SE0015244520
FIGI
BBG000PQRCV4
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. Its technology platforms include F.I.R.S.T. and n-CoDeR. The company was founded in 1996 and is headquartered in Lund, Sweden.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BOVNF is 3.29 USD — it has decreased by −30.03% in the past 24 hours. Watch Bioinvent International AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioinvent International AB stocks are traded under the ticker BOVNF.
We've gathered analysts' opinions on Bioinvent International AB future price: according to them, BOVNF price has a max estimate of 13.67 USD and a min estimate of 8.16 USD. Watch BOVNF chart and read a more detailed Bioinvent International AB stock forecast: see what analysts think of Bioinvent International AB and suggest that you do with its stocks.
BOVNF reached its all-time high on Jun 1, 2021 with the price of 7.18 USD, and its all-time low was 0.13 USD and was reached on May 13, 2019. View more price dynamics on BOVNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BOVNF stock is 42.92% volatile and has beta coefficient of 0.45. Track Bioinvent International AB stock price on the chart and check out the list of the most volatile stocks — is Bioinvent International AB there?
Today Bioinvent International AB has the market capitalization of 256.32 M, it has decreased by −3.37% over the last week.
Yes, you can track Bioinvent International AB financials in yearly and quarterly reports right on TradingView.
Bioinvent International AB is going to release the next earnings report on Aug 26, 2025. Keep track of upcoming events with our Earnings Calendar.
BOVNF net income for the last quarter is −11.57 M USD, while the quarter before that showed −10.52 M USD of net income which accounts for −9.99% change. Track more Bioinvent International AB financial stats to get the full picture.
No, BOVNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 19, 2025, the company has 114 employees. See our rating of the largest employees — is Bioinvent International AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bioinvent International AB EBITDA is −48.12 M USD, and current EBITDA margin is −1.01 K%. See more stats in Bioinvent International AB financial statements.
Like other stocks, BOVNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioinvent International AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioinvent International AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioinvent International AB stock shows the neutral signal. See more of Bioinvent International AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.